DNA hypermethylation of acetoacetyl-CoA synthetase contributes to inhibited cholesterol supply and steroidogenesis in fetal rat adrenals under prenatal nicotine exposure

Toxicology
Dong-Mei WuJie Ping

Abstract

Prenatal nicotine exposure is a risk factor for intrauterine growth retardation (IUGR). Steroid hormones synthesized from cholesterol in the fetal adrenal play an important role in the fetal development. The aim of this study is to investigate the effects of prenatal nicotine exposure on steroidogenesis in fetal rat adrenals from the perspective of cholesterol supply and explore the underlying epigenetic mechanisms. Pregnant Wistar rats were administered 1.0mg/kg nicotine subcutaneously twice a day from gestational day (GD) 7 to GD17. The results showed that prenatal nicotine exposure increased IUGR rates. Histological changes, decreased steroid hormone concentrations and decreased cholesterol supply were observed in nicotine-treated fetal adrenals. In the gene expression array, the expression of genes regulating ketone metabolic process decreased in nicotine-treated fetal adrenals. The following conjoint analysis of DNA methylation array with these differentially expressed genes suggested that acetoacetyl-CoA synthetase (AACS), the enzyme utilizing ketones for cholesterol supply, may play an important role in nicotine-induced cholesterol supply deficiency. Moreover, the decreased expression of AACS and increased DNA methylatio...Continue Reading

References

Apr 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·S BalasubramaniamM S Brown
May 2, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·D A Dempsey, N L Benowitz
Apr 28, 2004·Toxicon : Official Journal of the International Society on Toxinology·Deniz Yildiz
Aug 9, 2005·Early Human Development·Abigail L FowdenAlison J Forhead
Nov 22, 2005·Molecular and Cellular Endocrinology·Dayami Lopez, Mark P McLean
Mar 7, 2006·Lancet·C W WarrenUNKNOWN Global Tobacco Surveillance System (GTSS) collaborative group
Aug 10, 2006·Psychopharmacology·Shannon G MattaJeffrey M Zirger
Jan 9, 2007·Molecular and Cellular Endocrinology·Fredric B Kraemer
Oct 2, 2007·Endocrine·Alison C HollowayMark A Tarnopolsky
Feb 19, 2008·Best Practice & Research. Clinical Endocrinology & Metabolism·Christine GicquelYves Le Bouc
Jun 10, 2008·Best Practice & Research. Clinical Endocrinology & Metabolism·Jacques Beltrand, Claire Lévy-Marchal
Oct 22, 2008·Annals of Human Biology·Ali DelpishehBernard J Brabin
Feb 17, 2009·Obesity·Ryota NarishimaTetsuya Fukui
Nov 20, 2009·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Karine BibeauMichèle Brochu
Feb 17, 2010·Steroids·Daniel B Martinez-Arguelles, Vassilios Papadopoulos
May 6, 2011·The American Journal of Clinical Nutrition·Sylvain SebertMichael E Symonds
Sep 17, 2013·American Journal of Obstetrics and Gynecology·Jinying YangRobert E Garfield
Mar 1, 2014·The Journal of Endocrinology·Satoko HaenoHiroshi Yokota
Dec 9, 2014·Epigenetics : Official Journal of the DNA Methylation Society·Divya ChhabraDawn L DeMeo

❮ Previous
Next ❯

Citations

Mar 4, 2021·Environmental Science and Pollution Research International·Rui YanAndy T Y Lau

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.